Stryker forward PE SYK
Share price divided by analysts' consensus earnings for the next twelve months, since 1996.
- Today, Oct 23, 2026
- 19.3×
- 10-year median
- 25.9×
- Against its 10-year history
- 3rd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 17.0× to 35.5×
- Peer median
- 16.8×
Stryker's forward PE is 19.3× as of Oct 23, 2026.
That is below its ten-year median of 25.9×, lower than on 97% of days in the last ten years.
Over that time it ranged from 17.0× in Sep 2026 to 35.5× in Feb 2020.
The median for 7 medical device stocks of a similar size is 16.8×.
Forward PE over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 19.3× | 17.0× | 25.6× |
| 2025 | 24.6× | 24.6× | 30.8× |
| 2024 | 28.7× | 26.4× | 30.7× |
| 2023 | 26.8× | 23.8× | 30.1× |
| 2022 | 25.3× | 20.8× | 29.2× |
| 2021 | 29.3× | 24.2× | 30.2× |
| 2020 | 27.4× | 22.0× | 35.5× |
| 2019 | 33.8× | 20.1× | 34.1× |
| 2018 | 19.9× | 19.3× | 24.7× |
| 2017 | 22.7× | 19.3× | 23.4× |
| 2016 | 19.7× | 16.3× | 21.0× |
| 2015 | 17.2× | 16.9× | 19.7× |
| 2014 | 19.7× | 16.0× | 19.7× |
| 2013 | 16.6× | 13.7× | 16.6× |
| 2012 | 13.1× | 12.3× | 13.6× |
| 2011 | 12.4× | 11.3× | 17.3× |
| 2010 | 15.2× | 12.9× | 18.1× |
| 2009 | 16.1× | 10.8× | 16.6× |
| 2008 | 14.0× | 13.1× | 26.3× |
| 2007 | 27.5× | 24.5× | 28.6× |
Against its peers
Companies in Medical - Devices nearest Stryker's size, closest first, today.
| Company | Forward PE |
|---|---|
| SYKStryker | 19.3× |
| MDTMedtronic | 15.9× |
| ABTAbbott Laboratories | 17.7× |
| BSXBoston Scientific | 14.1× |
| EWEdwards Lifesciences | 28.3× |
| GEHCGE HealthCare Technologies | 13.8× |
| DXCMDexCom | 27.7× |
| ZBHZimmer Biomet | n/m |
| Peer median | 16.8× |
Where Stryker ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on Stryker
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.